Natural killer (NK) cells are part of the body’s innate immune system, able to recognize stressed or abnormal cells often without needing tumor specific markers. That makes NK therapy a promising, non surgical option under active clinical investigation worldwide. Outcomes vary by patient and cancer type, but growing evidence suggests certain cancers may respond.